Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.
about
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survivalBleeding related to disturbed fibrinolysisHemostatic function to regulate perioperative bleeding in patients undergoing spinal surgery: A prospective observational studyNoncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.Congenital alpha(2)-plasmin inhibitor deficiencies: a review.Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.Alpha II Antiplasmin Deficiency Complicating Pregnancy: A Case Report.alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorderSynthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell linesCross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factorSynergistic fibrinolysis: combined effects of plasminogen activators and an antibody that inhibits alpha 2-antiplasmin.Mannose trimming targets mutant alpha(2)-plasmin inhibitor for degradation by the proteasome.New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice.Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation.Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.Biological role of fibrinolysis.
P2860
Q24554422-E58D1DB6-6E29-48BB-8DEE-843F77229F3FQ28070127-2393525F-1BDD-4B6C-82EE-59D805C60A28Q33807064-D0E80594-9C00-4E4F-9B29-5643E95677ADQ34101596-62942DAC-F34F-4419-8555-4E3E24687B9CQ34319340-387D463A-16A4-42B9-AF82-0162D5F42CFEQ34529594-2FB274A8-4A6C-4F69-94D4-DB66D5FC0545Q34572566-3DDACDE0-AC49-4621-8DBA-66EB529FDE71Q34573519-2AF0D027-8719-42D1-B399-0EA7E5B85A26Q35101551-8097DB6D-098C-4516-B72C-23EE95F84B5DQ35581846-214B25DA-5562-4F22-95CC-4512A92829DBQ36312684-F588AE43-C559-4FD2-AD71-2A5DF66C46D9Q37020020-87C20657-64FE-4192-A927-E2ECC96F2262Q37687654-70A67375-6817-4A91-BBC8-FFE94EA7BE52Q38315499-8E4C0D9E-A700-4AB7-8AEB-BC84B81F78E9Q39157494-D039B05C-A7A9-4253-B02E-6E22E6385227Q40683743-A36617D8-27C6-4828-AF45-09072792DC6EQ40684825-6466B213-9536-44B8-B263-A61EABB036B5Q41476888-9EF3E2FC-0B53-4182-AD64-6408DF1948B1Q42127015-33DD4E08-A5D5-429D-AE41-0F901DEDCB57Q43182103-E4E31C33-27B3-465A-9951-814CC8488263
P2860
Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Congenital deficiency of alpha ...... h severe hemorrhagic tendency.
@en
Congenital deficiency of alpha ...... h severe hemorrhagic tendency.
@nl
type
label
Congenital deficiency of alpha ...... h severe hemorrhagic tendency.
@en
Congenital deficiency of alpha ...... h severe hemorrhagic tendency.
@nl
prefLabel
Congenital deficiency of alpha ...... h severe hemorrhagic tendency.
@en
Congenital deficiency of alpha ...... h severe hemorrhagic tendency.
@nl
P2093
P2860
P356
P1476
Congenital deficiency of alpha ...... h severe hemorrhagic tendency.
@en
P2093
P2860
P304
P356
10.1172/JCI109387
P407
P577
1979-05-01T00:00:00Z